Aethlon Medical Inc (AEMD)

[stockhorizon]

ITEM 3.01 Notification of Failure to Satisfy a Continued Listing Rule or Standard

On February 1, 2017, Aethlon Medical, Inc. (the “Company”) received a written notification from the Nasdaq Stock Market LLC that it has not met the minimum of $35,000,000 in Market Value of Listed Securities (“MVLS”) for the last 30 consecutive business days (from December 15, 2016-January 31, 2017) as set forth in Listing Rule 5550(b)(2).

The notification does not result in the delisting of the Company's common stock at this time, and its common stock will continue to trade on the Nasdaq Capital Market.

The Company has been provided with a 180 calendar day period (by July 31, 2017) in which to gain compliance by closing with an MVLS of at least $35,000,000 for any 10 consecutive business days during that period, and this matter would then be automatically closed.